Enhanced Topical Psoralen-UV-A Therapy via Targeting to Hair Follicles.

Enhanced Topical Psoralen-UV-A Therapy via Targeting to Hair Follicles.
Br J Dermatol. 2019 Dec 10;:
Authors: Svenskaya YI, Talnikova EE, Parakhonskiy BV, Tuchin VV, Sukhorukov GB, Gorin DA, Utz SR
Abstract
The renewed interest in Psoralen-UV-A (PUVA) therapy driven by impressive recent results in this field encourages the researchers and clinicians to shift the momentum back in its favor.1-3 As far as administration of low-cumulative UV-A doses minimizes the negative risks, the search for efficient modalities decreasing the frequency of sessions may help not to lose such therapeutic option.
PMID: 31821544 [PubMed - as supplied by publisher]

Source: The British Journal of Dermatology - December 9, 2019 Category: Dermatology Authors: Svenskaya YI, Talnikova EE, Parakhonskiy BV, Tuchin VV, Sukhorukov GB, Gorin DA, Utz SR Tags: Br J Dermatol Source Type: research